In vitro studies culturing tumor cells in 100% human serum demonstrated that a 2 μM concentration of sorafenib tosylate had single agent as well as combinatorial anti-tumor efficacy with HDAC inhibitors[79]. Here, HDAC9 is linked to neoplasm.